These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 23097983)
1. [The biochemical markers of endothelium dysfunction in patients with diabetic nephropathy]. Sibireva OF; Kaliuzhin VV; Urazova OI; Kaliuzhina EV; Milovanova TA Klin Lab Diagn; 2012 Aug; (8):8-11. PubMed ID: 23097983 [TBL] [Abstract][Full Text] [Related]
2. [Cardiorenal syndrome in type 1 diabetes mellitus: the role of endothelial dysfunction]. Shestakova MV; Iarek-Martynova IR; Ivanishina NS; Aleksandrov AA; Dedov II Kardiologiia; 2005; 45(6):35-41. PubMed ID: 16007033 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease. Hirano T; Ookubo K; Kashiwazaki K; Tajima H; Yoshino G; Adachi M Clin Chim Acta; 2000 Sep; 299(1-2):65-75. PubMed ID: 10900293 [TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174 [TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor and its propeptide in children with diabetes. Relation between endothelial dysfunction and microalbuminuria. Verrotti A; Greco R; Basciani F; Morgese G; Chiarelli F Pediatr Res; 2003 Mar; 53(3):382-6. PubMed ID: 12595584 [TBL] [Abstract][Full Text] [Related]
6. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy. Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207 [TBL] [Abstract][Full Text] [Related]
7. [Effect of von Willebrand factor and endothelin-1 on formation of thrombotic status in patients with ischemic heart disease]. Sokolov EI; Grishina TI; Shtin SR Kardiologiia; 2013; 53(3):25-30. PubMed ID: 23548423 [TBL] [Abstract][Full Text] [Related]
8. Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. Chen JW; Gall MA; Deckert M; Jensen JS; Parving HH BMJ; 1995 Nov; 311(7017):1405-6. PubMed ID: 8520276 [No Abstract] [Full Text] [Related]
9. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Caballero AE; Arora S; Saouaf R; Lim SC; Smakowski P; Park JY; King GL; LoGerfo FW; Horton ES; Veves A Diabetes; 1999 Sep; 48(9):1856-62. PubMed ID: 10480619 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus. Polat SB; Ugurlu N; Aslan N; Cuhaci N; Ersoy R; Cakir B Arch Endocrinol Metab; 2016 Apr; 60(2):117-24. PubMed ID: 26886090 [TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications. De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845 [TBL] [Abstract][Full Text] [Related]
12. [Vasoactive factors of the vascular endothelium in patients with non-insulin-dependent diabetes mellitus and kidney involvement]. Shakhmalova MSh; Shestakova MV; Chugunova LA; Dedov II Ter Arkh; 1996; 68(6):43-6. PubMed ID: 8771684 [TBL] [Abstract][Full Text] [Related]
13. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria. Gaede P; Vedel P; Parving HH; Pedersen O Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy]. Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Cheng YS Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):729-31. PubMed ID: 15958323 [TBL] [Abstract][Full Text] [Related]
15. In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Vermes I; Spooren PF; Kalsbeek-Batenburg EM; Haanen C Diabetologia; 1993 May; 36(5):472-3. PubMed ID: 8314455 [No Abstract] [Full Text] [Related]
16. [The endothelin-1 and von Willebrand factor in the development of lung hypertension in children with chronic bronchopulmonary pathology]. Agapitov LI; Belozerov IuM; Mizernitskiĭ IuL Klin Lab Diagn; 2012 Jan; (1):11-3. PubMed ID: 22545467 [TBL] [Abstract][Full Text] [Related]
17. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review. Hellemons ME; Kerschbaum J; Bakker SJ; Neuwirt H; Mayer B; Mayer G; de Zeeuw D; Lambers Heerspink HJ; Rudnicki M Diabet Med; 2012 May; 29(5):567-77. PubMed ID: 21913962 [TBL] [Abstract][Full Text] [Related]
18. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Parving HH; Nielsen FS; Bang LE; Smidt UM; Svendsen TL; Chen JW; Gall MA; Rossing P Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847 [TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Morise T; Takeuchi Y; Kawano M; Koni I; Takeda R Diabetes Care; 1995 Jan; 18(1):87-9. PubMed ID: 7698054 [TBL] [Abstract][Full Text] [Related]
20. Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy. Jensen T BMJ; 1989 Jan; 298(6665):27-8. PubMed ID: 2492846 [No Abstract] [Full Text] [Related] [Next] [New Search]